COVID-19 RESOURCES FOR HEALTHCARE PROFESSIONALS
Resources to help you determine the best treatment options for your patients with COVID-19.
Early intervention with monoclonal antibody treatment may reduce the risk of severe illness and hospitalization for people with COVID-19 who are at high risk of developing more serious illness. Here are resources that can help you ensure rapid access to monoclonal antibody treatment for your high-risk COVID-19 patients.
Is your healthcare practice interested in being a study site for an ACTIV clinical trial? Please email [email protected] with the email subject, “Potential Site for ACTIV Trials."
SUPPORT TOOLS FOR CLINICIANS
TOOLS FOR YOUR PRACTICE
Identification and Referral
Download a brief guide to identifying and referring high-risk patients.
Find a one-stop resource for guidance and instructions on preparing your facility, administering mAb treatments, and reporting therapeutic data and adverse events.
Billing and Reimbursement
Learn about Medicaid, Medicare, and commercial insurance coverage for mAb treatment.
Download a script you can use to inform patients they have tested positive for COVID-19.
HELP YOUR PATIENTS UNDERSTAND mAb TREATMENTS
Read a Frequently Asked Questions (FAQ) document to help answer patient questions.
Download "An Option for COVID-19 Positive Patients: Monoclonal Antibody Treatment" to help your patients understand how mAb treatment can help prevent more serious COVID-19 illness.
Download an informational poster for your practice.
CLINICAL EVIDENCE, GUIDELINES, AND VIDEOS
Clinical Evidence Summary
Read a summary of the clinical evidence and Emergency Use Authorizations (EUAs) for monoclonal antibodies.
Read a Provider FAQs document about the science.
Browse up-to-date resources for healthcare providers, including the April 2021 National Institutes of Health COVID-19 treatment guidelines, Centers for Disease Control and Prevention data on variants by state, EUA fact sheets, and more.
Hear from leading experts and watch a series on how to set up and manage infusion operations in your facility—from patient flow to safety to training.
COVID-19 CLINICAL TRIAL OPPORTUNITIES FOR YOUR PATIENTS
Find clinical trials for four patient categories: 1) Patients with COVID-19 who are not hospitalized; 2) Hospitalized COVID-19 patients; 3) Adults who have been exposed to COVID-19 but have not developed the disease; and 4) Adult patients who have been discharged from the hospital.
This document includes promising practices and recommendations from Maryland’s success in increasing the utilization of COVID-19 monoclonal antibody treatments. These findings provide inspiration and information to those working to build treatment awareness and demand and can supplement individual plans and provide context to playbooks and planning discussions with leadership.
FDA PROVIDER FACT SHEETS
Learn more about the products the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to help Combat COVID-19.
PEER REVIEWED ARTICLES
Explore the following peer-reviewed articles that discuss a range of COVID-19 treatment topics.